Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute – Mexico, from 2000 to 2016

by Jimena Ylescas‐Soria, Alfredo H. de la Torre‐Lujan, Luis A. Herrera, Daniela Miranda, Flavio Grimaldo, Silvia Rivas, Eduardo Cervera, Abelardo Meneses‐García, Fidias E. Leon-Sarmiento, Diddier Prada
Published 2019-06-01